Scobie I N, Saunders J, Barnes G D, Hoad J, Wheeler M J, Lowry C, Sonksen P H, Amphlett G, Riley A J
Curr Med Res Opin. 1986;10(5):285-90. doi: 10.1185/03007998609111092.
The effect of chronic oral administration of cimetidine (1 g per day) and ranitidine (300 mg per day) on plasma levels of prolactin (PRL), testosterone, dihydrotestosterone (DHT), luteinizing hormone (LH), follicle stimulating hormone (FSH), sex hormone binding globulin (SHBG) and human growth hormone was compared in 2 groups of male patients who presented with dyspeptic symptoms. Eight were treated with ranitidine and 9 with cimetidine for 4 weeks. The glucose and insulin response to a 100 g oral glucose load was also assessed. Cimetidine treatment resulted in a significant increase in plasma testosterone levels which was not found in the ranitidine group. No significant change occurred in PRL, LH, FSH, SHBG, DHT and growth hormone. There was no evidence of a significant alteration in carbohydrate metabolism.
在两组出现消化不良症状的男性患者中,比较了长期口服西咪替丁(每日1克)和雷尼替丁(每日300毫克)对催乳素(PRL)、睾酮、二氢睾酮(DHT)、促黄体生成素(LH)、促卵泡生成素(FSH)、性激素结合球蛋白(SHBG)和人生长激素血浆水平的影响。8名患者接受雷尼替丁治疗,9名患者接受西咪替丁治疗,为期4周。还评估了对100克口服葡萄糖负荷的血糖和胰岛素反应。西咪替丁治疗导致血浆睾酮水平显著升高,而雷尼替丁组未出现这种情况。PRL、LH、FSH、SHBG、DHT和生长激素无显著变化。没有证据表明碳水化合物代谢有显著改变。